Real World Assessment of People Living With Chronic Hepatitis B in Australia - Trial NCT04914611
Access comprehensive clinical trial information for NCT04914611 through Pure Global AI's free database. This phase not specified trial is sponsored by Kirby Institute and is currently Recruiting. The study focuses on Hepatitis B. Target enrollment is 10000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Kirby Institute
Timeline & Enrollment
N/A
Feb 17, 2022
Jul 01, 2027
Primary Outcome
Characterisation of HBV
Summary
The REACH-B study establishes an observational cohort study of people living with chronic
 hepatitis B from a national network, including a diverse range of services, to characterise
 and monitor hepatitis B linkage to care and treatment requirements amongst this population.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04914611
Non-Device Trial